OliX Pharmaceuticals,Inc 226950.KQ
226950.KQ
OliX Pharmaceuticals,Inc 347850.KQ
D&D Pharmatech 358570.KQ
GI Innovation, Inc. 085660.KQ
Chabiotech Co.,Ltd. 086900.KQ
Medy-Tox Inc. 475830.KQ
Orum Therapeutics, Inc. 950210.KS
Prestige BioPharma Limited 476060.KQ
Onconic Therapeutics 310210.KQ
Voronoi, Inc. 005257.KS
Green Cross Holdings Corporation
OliX Pharmaceuticals,Inc 347850.KQ
D&D Pharmatech 358570.KQ
GI Innovation, Inc. 085660.KQ
Chabiotech Co.,Ltd. 086900.KQ
Medy-Tox Inc. 475830.KQ
Orum Therapeutics, Inc. 950210.KS
Prestige BioPharma Limited 476060.KQ
Onconic Therapeutics 310210.KQ
Voronoi, Inc. 005257.KS
Green Cross Holdings Corporation
Performance
| Periode | 226950.KQ | 347850.KQ | 358570.KQ | 085660.KQ | 086900.KQ | 475830.KQ | 950210.KS | 476060.KQ | 310210.KQ | 005257.KS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 72.69 % | 191.41 % | 6.20 % | 5.90 % | -27.07 % | 27.22 % | -17.15 % | -23.28 % | 43.40 % | 27.40 % |
| YTD | 363.61 % | 252.55 % | 121.25 % | 2.41 % | -1.65 % | 60.78 % | -19.96 % | 16.79 % | 109.58 % | 14.72 % |
| 1Y | 203.10 % | 246.89 % | 34.92 % | -35.81 % | -31.63 % | 60.78 % | -17.65 % | 5.32 % | 43.89 % | 4.33 % |
| 3Y | 349.62 % | 424.55 % | 67.60 % | -12.29 % | 22.12 % | 60.78 % | 62.52 % | 5.32 % | 844.86 % | -35.37 % |
| 5Y | 176.42 % | 424.55 % | 67.60 % | -34.72 % | -23.62 % | 60.78 % | -75.46 % | 5.32 % | 588.93 % | -84.18 % |
| 10Y | 176.42 % | 424.55 % | 67.60 % | -24.41 % | -67.48 % | 60.78 % | -75.46 % | 5.32 % | 588.93 % | 3.31 % |
| Depuis le début | 176.42 % | 424.55 % | 67.60 % | 53.95 % | 871.99 % | 60.78 % | -75.46 % | 5.32 % | 588.93 % | 714.24 % |